Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 8, 2009, Leslie Hudson, Ph.D., notified the Chairman of the Board of
Nabi Biopharmaceuticals (the "Company") that he would not seek re-election as a
director of the Company at the Company's upcoming annual meeting of stockholders
scheduled for May 22, 2009 but would serve out the remainder of his current
term. Dr. Hudson currently is President, Chief Executive Officer and a director
of AVI BioPharma, Inc., a biopharmaceutical company based in Portland, Oregon.
Dr. Hudson's decision was personal and not based upon a difference of opinion
with the Company or other members of the Board of Directors.
Add
NABI to Portfolio
Set Alert
Email to a
Friend